Clinical Trial Update: Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of OMS302 in patients undergoing cataract surgery with intraocular lens replacement has completed, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• OMS302

Snippet

Sponsor: Omeros Corporation | Conditions: Intraocular Lens Replacement | Phase 3 | Status: COMPLETED | Results posted: 2014-08-21